{"id":"W2898091448","doi":"10.1007/s00280-018-3706-5","title":"Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)","year":2018,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Apotex (Canada)","funders":"National Health and Medical Research Council","keywords":"Carboplatin; Gemcitabine; Ovarian cancer; Medicine; Platinum; Internal medicine; Oncology; Chemotherapy; Phases of clinical research; Cancer; Cisplatin; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001233676,0.001518965,0.003607036,0.0006990506,0.000611284,0.001242723,0.001383089,0.001654681,0.005229725],"category_scores_gemma":[0.000637399,0.0009248485,0.002233807,0.0007725588,0.001184103,0.0008704988,0.0005983579,0.005053509,0.00136691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001288809,"about_ca_system_score_gemma":0.00297804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003778095,"about_ca_topic_score_gemma":0.009574304,"domain_scores_codex":[0.9995841,0.0001532564,0.00001659625,0.00007832667,0.00002609645,0.0001416297],"domain_scores_gemma":[0.9993462,0.00005579437,0.00006585197,0.00006643734,0.00002485089,0.0004407686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7005073,0.1099774,0.008493366,0.0009302108,0.002272281,0.0004364316,0.0005486545,0.00438208,0.04816233,0.0005618209,0.009857425,0.1138706],"study_design_scores_gemma":[0.5062448,0.4692235,0.0144325,0.00004244659,0.00067452,0.0003525192,0.0001094716,0.00103297,0.003570221,0.0002431764,0.004033003,0.0000408173],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989406,0.002259426,0.0004657029,0.0006731625,0.0001886594,0.00246658,0.001969756,0.0001672155,0.002403377],"genre_scores_gemma":[0.9798148,0.003106997,0.001720996,0.001416143,0.0001726258,0.003000929,0.006167027,0.00009591274,0.004504537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005229725,"threshold_uncertainty_score":0.01749516,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02789298406971904,"score_gpt":0.3651652371962587,"score_spread":0.3372722531265397,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}